Tag Archives: immuno-oncology

Merck Ventures forms immuno-oncology spin-out company Onctura SA in Geneva, Switzerland

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment The company will progress its portfolio of assets seamlessly into clinical evaluation, in collaboration with one of its shareholders Cancer Research Technology (CRT) The … Read the full press release

Sanofi, Regeneron Pharmaceuticals partner to discover, develop and commercialize new antibody cancer treatments in the emerging field of immuno-oncology

Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies – Sanofi commits to an initial investment of up to $2.17 billion in the exclusive collaboration, including $640 million in upfront payments to Regeneron … Read the full press release

AstraZeneca and MedImmune presented encouraging results from their novel combination-focused immuno-oncology portfolio at ASCO Annual Meeting 2015

LONDON, 2-6-2015 — /EuropaWire/ — AstraZeneca and MedImmune, the company’s global biologics research and development arm, today presented encouraging results from their novel combination-focused immuno-oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting 2015. Overall, data indicated … Read the full press release